Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-11-17

FDA Approved: ZOLPIDEM — Supplemental Application (ACI Healthcare USA, Inc)

View source ↗

Summary

FDA approved a supplemental application for zolpidem tartrate submitted by ACI Healthcare USA, Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem (zolpidem)

Snippet

SUPPL AP for ZOLPIDEM (ZOLPIDEM TARTRATE)